Brendan Teehan - 31 Dec 2025 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Commercial Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
31 Dec 2025
Net transactions value
+$4,330
Form type
4
Filing time
06 Jan 2026, 17:30:28 UTC
Previous filing
04 Feb 2025
Next filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Teehan Brendan Chief Commercial Officer C/O PACIRA BIOSCIENCES, INC., 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE /s/ Kristen Williams, Attorney-in-Fact 06 Jan 2026 0001891900

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Award $4,330 +402 +0.74% $10.76 54,402 31 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.